Market Opportunities of Parkinson's Disease Treatment Globally in Next 5 Years

Parkinson's Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics)

(EMAILWIRE.COM, April 08, 2019 ) Parkinson’s disease treatment is used to treat the symptoms of Parkinson’s disease, generally, medication is the first line treatment for this disease.

The global Parkinson’s disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247

Rising geriatric population and government funding for research on Parkinson’s disease are the driving factors for this market.

Target Audience for this Report:
-Parkinson’s disease treatment product manufacturers
-Parkinson’s disease treatment dealers and suppliers
-Human identification service providers
-Parkinson’s disease associations
-Academic institutions
-Venture capitalists
-Consulting firms
-Government bodies

By region, the Parkinson’s disease treatment market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).

The market is dominated by Europe, followed by North America, however, the Asian region is expected to witness the highest growth during the forecast period. Asia is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India.

The increasing number of generic drug manufacturers and rising aging populaion across are key factors driving the Parkinson’s disease treatment market in Asia. However, availability of alternative treatments is going to restrain this market.

Speak to Our Expert @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=47265247